Qualified candidates should possess strong analytical and problem-solving skills, with a thorough understanding of clinical supply processes and IRT systems. Experience in managing cross-functional teams and projects within a clinical trial environment is essential. Familiarity with regulatory requirements and quality assurance processes is highly desirable. Excellent communication skills, both written and verbal, are necessary to collaborate effectively with various stakeholders.
About the job
Adverum Biotechnologies, Inc., a proud subsidiary of Eli Lilly and Company, is a pioneering clinical-stage organization dedicated to revolutionizing gene therapy for widely prevalent ocular diseases. Our mission is to develop functional cures that restore vision and prevent blindness, thereby transforming the standard of care. Utilizing our proprietary intravitreal (IVT) platform, we are creating durable, single-administration therapies that can be delivered conveniently in physicians’ offices, eliminating the need for frequent ocular injections. By addressing the challenges associated with current treatment methodologies for these debilitating conditions, Adverum aims to make a significant global impact on vision preservation.
The Manager, Clinical Supply IRT plays a crucial role in our clinical trials, overseeing the strategy, design, configuration, validation, and lifecycle management of Interactive Response Technology (IRT) systems. This position serves as an essential connector among Clinical Operations, Clinical Supply Chain, Quality Assurance (QA), Packaging/Labeling, Depots, and IRT vendors. The primary objective is to ensure the precise translation of subject randomization, site activation, inventory management, resupply logic, and shipment triggers into effective system design and operational execution.
About Adverum
Adverum Biotechnologies, Inc. is at the forefront of gene therapy innovation, aiming to set new standards in the treatment of ocular diseases. With a dedicated focus on developing transformative therapies, Adverum is committed to preserving vision and creating a profound societal impact globally.
This job posting is no longer active and is not accepting applications.
Qualified candidates should possess strong analytical and problem-solving skills, with a thorough understanding of clinical supply processes and IRT systems. Experience in managing cross-functional teams and projects within a clinical trial environment is essential. Familiarity with regulatory requirements and quality assurance processes is highly desirable. Excellent communication skills, both written and verbal, are necessary to collaborate effectively with various stakeholders.
About the job
Adverum Biotechnologies, Inc., a proud subsidiary of Eli Lilly and Company, is a pioneering clinical-stage organization dedicated to revolutionizing gene therapy for widely prevalent ocular diseases. Our mission is to develop functional cures that restore vision and prevent blindness, thereby transforming the standard of care. Utilizing our proprietary intravitreal (IVT) platform, we are creating durable, single-administration therapies that can be delivered conveniently in physicians’ offices, eliminating the need for frequent ocular injections. By addressing the challenges associated with current treatment methodologies for these debilitating conditions, Adverum aims to make a significant global impact on vision preservation.
The Manager, Clinical Supply IRT plays a crucial role in our clinical trials, overseeing the strategy, design, configuration, validation, and lifecycle management of Interactive Response Technology (IRT) systems. This position serves as an essential connector among Clinical Operations, Clinical Supply Chain, Quality Assurance (QA), Packaging/Labeling, Depots, and IRT vendors. The primary objective is to ensure the precise translation of subject randomization, site activation, inventory management, resupply logic, and shipment triggers into effective system design and operational execution.
About Adverum
Adverum Biotechnologies, Inc. is at the forefront of gene therapy innovation, aiming to set new standards in the treatment of ocular diseases. With a dedicated focus on developing transformative therapies, Adverum is committed to preserving vision and creating a profound societal impact globally.